Nothing Special   »   [go: up one dir, main page]

Sijbesma et al., 2017 - Google Patents

Identification of two secondary ligand binding sites in 14-3-3 proteins using fragment screening

Sijbesma et al., 2017

View PDF
Document ID
12330626080435273633
Author
Sijbesma E
Skora L
Leysen S
Brunsveld L
Koch U
Nussbaumer P
Jahnke W
Ottmann C
Publication year
Publication venue
Biochemistry

External Links

Snippet

Proteins typically interact with multiple binding partners, and often different parts of their surfaces are employed to establish these protein–protein interactions (PPIs). Members of the class of 14-3-3 adapter proteins bind to several hundred other proteins in the cell. Multiple …
Continue reading at pubs.acs.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Similar Documents

Publication Publication Date Title
Sijbesma et al. Identification of two secondary ligand binding sites in 14-3-3 proteins using fragment screening
Almo et al. Structural genomics of protein phosphatases
Karatas et al. Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)–mixed lineage leukemia (MLL) protein–protein interaction
Bai et al. Targeting self-binding peptides as a novel strategy to regulate protein activity and function: a case study on the proto-oncogene tyrosine protein kinase c-Src
Uversky et al. Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases
Bier et al. The molecular tweezer CLR01 stabilizes a disordered protein–protein interface
Michelsen et al. Ordering of the N-terminus of human MDM2 by small molecule inhibitors
Bezerra et al. Entropy-driven binding of opioid peptides induces a large domain motion in human dipeptidyl peptidase III
Jones et al. Role of the D-loops in allosteric control of ATP hydrolysis in an ABC transporter
Krüger et al. Structure-based design of non-natural macrocyclic peptides that inhibit protein–protein interactions
Showalter et al. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft
Henderson et al. Antimicrobial peptide resistance of Vibrio cholerae results from an LPS modification pathway related to nonribosomal peptide synthetases
Guillory et al. Fragment-based differential targeting of PPI stabilizer interfaces
Giżyńska et al. Proline-and arginine-rich peptides as flexible allosteric modulators of human proteasome activity
Ahn et al. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1
Begnini et al. Mining natural products for macrocycles to drug difficult targets
Zhang et al. The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear
Andrei et al. Inhibition of 14-3-3/tau by hybrid small-molecule peptides operating via two different binding modes
Mori et al. Small molecules modulation of 14-3-3 protein–protein interactions
Weng et al. Uncovering the mechanism of forkhead-associated domain-mediated TIFA oligomerization that plays a central role in immune responses
Rühmann et al. Fragment binding can be either more enthalpy-driven or entropy-driven: crystal structures and residual hydration patterns suggest why
Sammons et al. A novel class of common docking domain inhibitors that prevent ERK2 activation and substrate phosphorylation
Velazquez et al. Conformational selection in the recognition of phosphorylated substrates by the catalytic domain of human Pin1
Sohn et al. Experimental Validation of the Docking Orientation of Cdc25 with Its Cdk2− CycA Protein Substrate
Maben et al. Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism